{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:37:53Z","timestamp":1773232673147,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPVVM0153"],"award-info":[{"award-number":["CMRPVVM0153"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPVVM0152"],"award-info":[{"award-number":["CMRPVVM0152"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CORPVVL0031"],"award-info":[{"award-number":["CORPVVL0031"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPVVM0151"],"award-info":[{"award-number":["CMRPVVM0151"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG3M0483"],"award-info":[{"award-number":["CORPG3M0483"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3N1522"],"award-info":[{"award-number":["CMRPG3N1522"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPVVL0032"],"award-info":[{"award-number":["CORPVVL0032"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jiph.2025.102989","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:57:20Z","timestamp":1760072240000},"page":"102989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PhenoAge acceleration predicts antibody persistence and breakthrough infection after SARS-CoV-2 vaccination and infection"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7814-4723","authenticated-orcid":false,"given":"Jeng-How","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7506-9032","authenticated-orcid":false,"given":"Ya-Fang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry Yueh-Hsia","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Wen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Chung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Mei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-409X","authenticated-orcid":false,"given":"Jason Chia-Hsun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-020-0190-2","article-title":"Overview of lethal human coronaviruses","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"10223","key":"10.1016\/j.jiph.2025.102989_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"6543","key":"10.1016\/j.jiph.2025.102989_bib3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.abj0016","article-title":"Investigate the origins of COVID-19","volume":"372","author":"Bloom","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jiph.2025.102989_bib4","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Rep Med"},{"issue":"7","key":"10.1016\/j.jiph.2025.102989_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.jiph.2025.102989_bib6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jama.2021.4388","article-title":"Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination","volume":"325","author":"Edara","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jiph.2025.102989_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid decay of Anti-SARS-CoV-2 antibodies in persons with mild covid-19","volume":"383","author":"Ibarrondo","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jiph.2025.102989_bib8","first-page":"2588","article-title":"Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset","volume":"136","author":"Perreault","year":"2020","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102989_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/infdis\/jiab255","article-title":"Persistence of antibody and cellular immune responses in coronavirus disease 2019 patients over nine months after infection","volume":"224","author":"Yao","year":"2021","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.102989_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiph.2025.102989_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101174","article-title":"Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection","volume":"41","author":"Lau","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jiph.2025.102989_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jiac.2021.01.006","article-title":"Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19","volume":"27","author":"Kutsuna","year":"2021","journal-title":"J Infect Chemother"},{"issue":"8","key":"10.1016\/j.jiph.2025.102989_bib13","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/gerona\/glab060","article-title":"Biological aging predicts vulnerability to COVID-19 severity in UK biobank participants","volume":"76","author":"Kuo","year":"2021","journal-title":"J Gerontol Ser A"},{"key":"10.1016\/j.jiph.2025.102989_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631139","article-title":"A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic","volume":"12","author":"Triggle","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102989_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215840120","article-title":"Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality","volume":"120","author":"Faul","year":"2023","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.jiph.2025.102989_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002718","article-title":"A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study","volume":"15","author":"Liu","year":"2018","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.jiph.2025.102989_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae232","article-title":"Accelerated phenotypic aging associated with hepatitis c infection: results from the US National Health and Nutrition Examination Surveys 2015\u20132018","volume":"79","author":"Tao","year":"2024","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.jiph.2025.102989_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1034227","article-title":"Accelerated ageing is associated with increased COVID-19 severity and differences across ethnic groups may exist","volume":"10","author":"Reeves","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib19","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41467-022-29801-8","article-title":"Accelerated biological aging in COVID-19 patients","volume":"13","author":"Cao","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jiph.2025.102989_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12996","article-title":"Demographic and clinical factors associated with anti-SARS-CoV-2 antibody levels after 2 BNT162b2 mRNA vaccine doses","volume":"5","author":"Nam","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiph.2025.102989_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114271","article-title":"Performance evaluation of the Roche Elecsys anti-SARS-CoV-2 s immunoassay","volume":"297","author":"Riester","year":"2021","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7774\/cevr.2022.11.1.96","article-title":"Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (moderna) vaccination against SARS-CoV-2 in health care workers","volume":"11","author":"Kr\u00fcttgen","year":"2022","journal-title":"Clin Exp Vaccin Res"},{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41598-021-04344-y","article-title":"Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection","volume":"12","author":"Gianfagna","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jiph.2025.102989_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/vaccines9070714","article-title":"Antibodies responses to SARS-CoV-2 in a large cohort of vaccinated subjects and seropositive patients","volume":"9","author":"Amodio","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.jiph.2025.102989_bib25","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101492R","article-title":"Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination","volume":"36","author":"Shapira","year":"2022","journal-title":"FASEB J"},{"issue":"37","key":"10.1016\/j.jiph.2025.102989_bib26","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1016\/j.vaccine.2020.06.082","article-title":"A global agenda for older adult immunization in the COVID-19 era: a roadmap for action","volume":"39","author":"Privor-Dumm","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib27","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.jiph.2025.102989_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/v16030479","article-title":"Predicting vaccine effectiveness for hospitalization and symptomatic disease for novel SARS-CoV-2 variants using neutralizing antibody titers","volume":"16","author":"Gardner","year":"2024","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jiph.2025.102989_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.vaccine.2021.11.081","article-title":"SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study","volume":"40","author":"Herzberg","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jiph.2025.102989_bib30","article-title":"Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections","author":"Gazit","year":"2021","journal-title":"MedRxiv"},{"issue":"2","key":"10.1016\/j.jiph.2025.102989_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/cid\/ciae559","article-title":"Optimal annual COVID-19 vaccine boosting dates following previous booster vaccination or breakthrough infection","volume":"80","author":"Townsend","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.102989_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102989_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1259","article-title":"Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: a systematic review","volume":"12","author":"Bytyci","year":"2024","journal-title":"Immun Inflamm Dis"},{"issue":"7","key":"10.1016\/j.jiph.2025.102989_bib34","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11255-021-03059-3","article-title":"Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients","volume":"54","author":"Loutradis","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102989_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eprac.2021.02.013","article-title":"Association of vitamin d status with hospital morbidity and mortality in adult hospitalized patients with COVID-19","volume":"27","author":"Charoenngam","year":"2021","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.jiph.2025.102989_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/microorganisms10050857","article-title":"SARS-CoV-2 vaccine alpha and delta variant breakthrough infections are rare and mild but can happen relatively early after vaccination","volume":"10","author":"Peter","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.jiph.2025.102989_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14740\/jocmr4662","article-title":"A retrospective cross-sectional study of severe breakthrough SARS-CoV-2 infection in the general population requiring hospitalization within a single health system","volume":"14","author":"Acharya","year":"2022","journal-title":"J Clin Med Res"},{"issue":"4","key":"10.1016\/j.jiph.2025.102989_bib38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/v14040802","article-title":"Incidence and risk factors of COVID-19 vaccine breakthrough infections: a prospective cohort study in Belgium","volume":"14","author":"Stouten","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.jiph.2025.102989_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002718","article-title":"A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: a cohort study","volume":"15","author":"Liu","year":"2018","journal-title":"PLoS Med"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:07:47Z","timestamp":1773158867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1876034125003387"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102989","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PhenoAge acceleration predicts antibody persistence and breakthrough infection after SARS-CoV-2 vaccination and infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102989"}}